Markers of increased cardiovascular risk: Are we measuring the most appropriate parameters?

被引:19
作者
Hawkins, MA [1 ]
机构
[1] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Ctr Diabet Res & Training, Bronx, NY 10461 USA
来源
OBESITY RESEARCH | 2004年 / 12卷
关键词
cardiovascular disease risk; high-density lipoprotein/total cholesterol ratio; small dense low-density lipoproteins; C-reactive protein; postprandial glucose levels;
D O I
10.1038/oby.2004.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vital task of evaluating cardiovascular disease risk in individual patients is challenging in light of the ever-growing list of risk factors. Some of the traditional measures of cardiovascular risk, such as blood lipid levels, have been further refined to provide better risk assessments. Certain specific parameters, such as lipoprotein buoyancy, seem to be better predictors of cardiovascular disease than total lipoprotein levels. Furthermore, as the contribution of systemic inflammation to the pathogenesis of atherosclerosis is increasingly. recognized, several inflammatory markers have become associated with disease risk. Consequently, many studies have attempted to determine the individual merits of these factors in predicting cardiovascular risk.
引用
收藏
页码:107S / 114S
页数:8
相关论文
共 54 条
[31]   FACTORS RESPONSIBLE FOR IMPAIRED FIBRINOLYSIS IN OBESE SUBJECTS AND NIDDM PATIENTS [J].
MCGILL, JB ;
SCHNEIDER, DJ ;
ARFKEN, CL ;
LUCORE, CL ;
SOBEL, BE .
DIABETES, 1994, 43 (01) :104-109
[32]   Depot-related gene expression in human subcutaneous and omental adipocytes [J].
Montague, CT ;
Prins, JB ;
Sanders, L ;
Zhang, JL ;
Sewter, CP ;
Digby, J ;
Byrne, CD ;
O'Rahilly, S .
DIABETES, 1998, 47 (09) :1384-1391
[33]   Pathways from obesity to hypertension: from the perspective of a vicious triangle [J].
Montani, JP ;
Antic, V ;
Yang, Z ;
Dulloo, A .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 2) :S28-S38
[34]   Inflammatory markers of coronary risk [J].
Rader, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) :1179-1182
[35]   Mechanisms of disease - Hypertension and associated metabolic abnormalities - The role of insulin resistance and the sympathoadrenal system [J].
Reaven, GM ;
Lithell, H ;
Landsberg, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :374-381
[36]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[37]   C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction [J].
Ridker, PM ;
Glynn, RJ ;
Hennekens, CH .
CIRCULATION, 1998, 97 (20) :2007-2011
[38]   C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events [J].
Ridker, PM ;
Buring, JE ;
Cook, NR ;
Rifai, N .
CIRCULATION, 2003, 107 (03) :391-397
[39]   Clinical application of C-reactive protein for cardiovascular disease detection and prevention [J].
Ridker, PM .
CIRCULATION, 2003, 107 (03) :363-369
[40]   Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J].
Ridker, PM ;
Cushman, M ;
Stampfer, MJ ;
Tracy, RP ;
Hennekens, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :973-979